Inclusion/exclusion criteria for trial participation.
Cancer
CANCER
This is an approved protocol at the National Cancer Institute, National Institutes of Health through the Scientific Review Board and Institutional Review Board (accepted 4/15/2022). Subsequently approved by ethics committees and NCI CTEP within NIH. Formal consent includes oral and written provided by the patient and/or their legal guardian by proxy, when appropriate.